Work

1079P Biparatopic anti-HER2 antibody drug conjugate (ADC) JSKN003 in the treatment of primary platinum-refractory ovarian cancer (OC)

Year: 2025

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.1717

Authors: X. Wu, J. Li, Y. Chen, Q. Rao, A. Lin, G. Weng, Z. Zhang, B. Liu, C. Lan, Q. Li, D. Tang, J. Dai, T. Xu

Institutions: Fudan University Shanghai Cancer Center, Zhejiang Cancer Hospital, Sun Yat-sen Memorial Hospital, Fujian Provincial Cancer Hospital, Linyi People's Hospital, Shandong Tumor Hospital, Shandong First Medical University, Sun Yat-sen University Cancer Center, Shanghai East Hospital, Hunan Cancer Hospital, Zhongnan Hospital of Wuhan University, Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (China)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415940888

FWCI: 0.409

Cites:

Cited by: 1

Related to: 10